SERPINA1 and pulmonary emphysema: Previous studies reported that the dominant pulmonary NE inhibitor, alpha1-antitrypsin (α1AT)-deficient patients exhibit rapidly progressive emphysematous-like conditions and early onset emphysema [34,35].